EOM Pharmaceuticals Report issue

For profit Phase 1 Phase 3
Founded: Montvale NJ United States (2020)

Organization Overview

First Clinical Trial
2021
NCT05212532
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

EOM Pharmaceuticals

Active Ingredients

Drugs in Phase 3 Trials (1)

Key: EOM Pharmaceuticals (0) Acquired (1)

ict-107 (2 trials)

Drugs in Phase 1 Trials (2)

Key: EOM Pharmaceuticals (1) Acquired (1)

eom613 (1 trial)

ict-121 dc vaccine (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 3